Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.

Autor: Abrams, Paul1, Cardozo, Linda2, Chapple, Christopher3, Serdarevic, Dzelal4 dzelal.serdarevic@pfizer.com, Hargreaves, Katherine4, Khular, Vikram5
Zdroj: International Journal of Urology. Jun2006, Vol. 13 Issue 6, p692-698. 7p. 3 Charts, 4 Graphs.
Databáze: Academic Search Ultimate